In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 42 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
19 authors at 6 institutions in 4 countries.
Xiao YanMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); Dresden, Saxony, 01307; Germany.ORCID 0000-0002-2933-7702 David KusterMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); Dresden, Saxony, 01307; Germany.ORCID 0000-0002-8157-9223 Priyesh MohantyArtie McFerrin Department of Chemical Engineering, Texas A&M University; College Station, TX 77843; USA.ORCID 0000-0003-3919-3527 Jik NijssenMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); Dresden, Saxony, 01307; Germany.ORCID 0000-0003-0013-9750 Karina Pombo-GarcíaMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); Dresden, Saxony, 01307; Germany.ORCID 0000-0002-2077-5909 Azamat RizuanArtie McFerrin Department of Chemical Engineering, Texas A&M University; College Station, TX 77843; USA.ORCID 0000-0003-3590-0829 Titus M FranzmannBiotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering, Technische Universität Dresden; Dresden, Saxony, 01307; Germany.ORCID 0000-0002-4281-7209 Aleksandra SergeevaMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); Dresden, Saxony, 01307; Germany.ORCID 0000-0003-0117-9076 Patricia M PassosEdward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University; St. Louis, MO 63104; USA.
Leah GeorgeEdward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University; St. Louis, MO 63104; USA.
Szu-Huan WangDepartment of Molecular Biology, Cell Biology & Biochemistry, Brown University; Providence, RI 02912; USA.
Jayakrishna ShenoyDepartment of Molecular Biology, Cell Biology & Biochemistry, Brown University; Providence, RI 02912; USA.
Helen L DanielsonCenter for Biomedical Engineering, Brown University; Providence, RI 02912; USA.
Alf HonigmannBiotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering, Technische Universität Dresden; Dresden, Saxony, 01307; Germany.
Yuna M AyalaEdward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University; St. Louis, MO 63104; USA.ORCID 0000-0003-4688-6583 Nicolas L FawziDepartment of Molecular Biology, Cell Biology & Biochemistry, Brown University; Providence, RI 02912; USA.ORCID 0000-0001-5483-0577 Jeetain MittalArtie McFerrin Department of Chemical Engineering, Texas A&M University; College Station, TX 77843; USA.ORCID 0000-0002-9725-6402 Simon AlbertiBiotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering, Technische Universität Dresden; Dresden, Saxony, 01307; Germany.ORCID 0000-0003-4017-6505 Anthony A HymanMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); Dresden, Saxony, 01307; Germany.ORCID 0000-0003-0851-704X Max Planck Institute of Molecular Cell Biology and Genetics · DECenter for Systems Biology Dresden · DECollege Station Medical Center · USJohn Brown University · USSaint Louis University · ESProvidence College · US
Funding
Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementiaR01NS114289 · NINDS · SAINT LOUIS UNIVERSITY · PI AYALA, YUNA · 2020 to 2024
$1.9MNINDS NIH HHS R01 NS114289
6 · The paper itselfAbstract
Cytosolic aggregation of the nuclear protein TDP-43 is associated with many neurodegenerative diseases, but the triggers for TDP-43 aggregation are still debated. Here, we demonstrate that TDP-43 aggregation requires a double event. One is up-concentration in stress granules beyond a threshold, and the other is oxidative stress. These two events collectively induce intra-condensate demixing, giving rise to a dynamic TDP-43 enriched phase within stress granules, which subsequently transitions into pathological aggregates. Mechanistically, intra-condensate demixing is triggered by local unfolding of the RRM1 domain for intermolecular disulfide bond formation and by increased hydrophobic patch interactions in the C-terminal domain. By engineering TDP-43 variants resistant to intra-condensate demixing, we successfully eliminate pathological TDP-43 aggregates in cells. We conclude that up-concentration inside condensates and simultaneous exposure to environmental stress could be a general pathway for protein aggregation, with intra-condensate demixing constituting a key intermediate step.
Indexed as
ALSintra-condensate demixingmultiphasic condensateneurodegenerative diseasesphase separationprotein aggregationstress granulesTDP-43
Identifiers
PMID38328053
PMCPMC10849624
OpenAlexW4391126650
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390